PMC:7190487 / 6331-6676
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 84-91 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | Glucose |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T43 | 84-91 | Body_part | denotes | Glucose | http://purl.org/sig/ont/fma/fma82743 |
| T44 | 128-136 | Body_part | denotes | Glucagon | http://purl.org/sig/ont/fma/fma83350 |
| T45 | 204-211 | Body_part | denotes | Insulin | http://purl.org/sig/ont/fma/fma83365 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T40 | 242-250 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T41 | 268-276 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T102 | 142-149 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | Peptide |
| T103 | 204-211 | http://purl.obolibrary.org/obo/PR_000009054 | denotes | Insulin |
| T104 | 284-286 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T80 | 84-91 | Chemical | denotes | Glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_42758 |
| T83 | 106-116 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T84 | 128-136 | Chemical | denotes | Glucagon | http://purl.obolibrary.org/obo/CHEBI_5391 |
| T85 | 142-149 | Chemical | denotes | Peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T86 | 182-194 | Chemical | denotes | Pioglitazone | http://purl.obolibrary.org/obo/CHEBI_8228 |
| T87 | 204-211 | Chemical | denotes | Insulin | http://purl.obolibrary.org/obo/CHEBI_5931 |
| T88 | 322-331 | Chemical | denotes | metformin | http://purl.obolibrary.org/obo/CHEBI_6801 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T58 | 84-103 | http://purl.obolibrary.org/obo/GO_1904659 | denotes | Glucose-Transporter |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T53 | 0-345 | Sentence | denotes | Although recent discussions point out that oral hypoglycaemic agents such as Sodium-Glucose-Transporter-2 inhibitors (SGLT-2i), Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1RAs), Pioglitazone and even Insulin might actually be harmful for COVID-19 individuals with diabetes [21], [22], limited evidence is available on metformin for the same. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 267 | 204-211 | Gene | denotes | Insulin | Gene:3630 |
| 276 | 84-91 | Chemical | denotes | Glucose | MESH:D005947 |
| 277 | 182-194 | Chemical | denotes | Pioglitazone | MESH:D000077205 |
| 278 | 322-331 | Chemical | denotes | metformin | MESH:D008687 |
| 285 | 242-250 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 286 | 268-276 | Disease | denotes | diabetes | MESH:D003920 |